MedPath

Cocoa Flavanols and Painfree Walking Distance

Phase 1
Completed
Conditions
Peripheral Artery Disease
Diabetes Mellitus
Interventions
Other: cocoa
Registration Number
NCT01064583
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

To characterize potential vascular long-term effects of flavanols in patients with peripheral artery occlusive disease (PAOD), a placebo-controlled double-blinded randomized control study will be performed in 62 patients randomized in two groups. Patients will twice daily receive either a flavanol-poor cocoa drink or a flavanol-rich cocoa drink over a period of 60 days months.

Detailed Description

62 Type 2 diabetics according to the criteria of the American Diabetes Association suffering from PAOD with a pain free walking distance less than 250m will be enrolled.

Patients will twice daily receive either a flavanol-poor cocoa drink (13mg/dl)or a flavanol-rich cocoa drink (596mg/dl) over a period of 60 days.

The general condition, the pain free walking distance and the vascular function measured by Doppler Ultrasound will be determined before and two month after cocoa ingestion

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • peripheral artery disease (Fontaine IIb)
  • diabetes mellitus
  • > 18 years
Exclusion Criteria
  • acute and terminal renal failure
  • acute infection
  • heart failure (NYHA III-IV)
  • arrhythmias

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
flavanol rich cocoa drink (596mg)cocoadissolved in water, twice daily intervention
flavanol poor cocoa drink ( 13mg)cocoadissolved in water, twice daily intervention
Primary Outcome Measures
NameTimeMethod
painfree walking distance60 days
Secondary Outcome Measures
NameTimeMethod
endothelial function60 days

Trial Locations

Locations (1)

Heinrich Heine University

🇩🇪

Düsseldorf, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath